Prevalence and disease progression of genetically-confirmed facioscapulohumeral muscular dystrophy type 1 (FSHD1) in China between 2001 and 2020: a nationwide population-based study

Figures

• 

  Figure 1. Distribution of families with genetically-confirmed FSHD1 in China, 2001-2020.

• 

  Figure 2. Prevalence of genetically-confirmed FSHD1 in China, 2001–2020.

• 

  Figure 3. Prediction of independent ambulation loss among patients with genetically-confirmed FSHD1. Curves are unadjusted for covariates. End point was defined as losing independent ambulation based on the modified Rankin Scale (mRS) with a grade of 4-5.